IBM computers and Microsoft software have been mainstays of biomedical studies for years. But, in the past decade, software and technology companies have increasingly been taking a more active role in biological research. Monica Heger profiles four of the movers and shakers who have been leading the charge.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heger, M. Tech meets bio. Nat Med 16, 844–847 (2010). https://doi.org/10.1038/nm0810-844
Issue Date:
DOI: https://doi.org/10.1038/nm0810-844